期刊文献+

血浆NT-proBNP和APACHE Ⅱ评分在难治性心衰患者预后中的价值研究 被引量:2

Evaluation of the Plasma NT-proBNP and APACHE Ⅱ Score in the Prognosis for Patients with Refractory Congestive Heart Failure
下载PDF
导出
摘要 目的探讨血浆N末端脑钠肽原(NT-proBNP)水平及急性生理与慢性健康评分(APACHEⅡ评分)与难治性心力衰竭患者预后的相关性及其在预后评价中的应用价值。方法选择2016年3月—2017年9月在医院ICU接受治疗的50例难治性心衰患者作为研究对象,所有患者入科30mim内抽取静脉血检测NT-ProBNP值,在患者入科后24h内临床表现最严重时进行APACHEⅡ评分。根据28d生存情况将所有患者分为存活组(38例)和死亡组(12例)。比较两组患者NT-ProBNP间及水平APACHEⅡ评分,计算NT-ProBNP与APACHEⅡ评分之间的相关性。结果死亡组患者的血浆NT-proBNP水平及APACHEⅡ评分均明显高于存活组患者(P<0.05);入科时NT-proBNP水平及APACHEⅡ评分显著相关(P<0.05),且二者与难治性心力衰竭患者预后显著相关(P<0.05)。结论难治性心力衰竭患者进入ICU时的血浆NT-proBNP水平及APACHEⅡ评分密切相关,且二者与患者预后之间存在相关性,可作为患者短期生存状态的预测因子。 Objective To investigate the correlation between plasma Plasma N-terminal ProBrain Natriureticpeptide,( NT-proBNP) levels,Acute Physiology and Chronic Health Evaluation( APACHE Ⅱ) score and the prognosis for patients with refractory congestive heart failure and the value of such correlation in prognosis evaluation. Methods We observed 50 patients with refractory heart failure who were admitted to ICU in our hospital from March 2016 to September 2017.Their venous blood samples were collected within 30 minutes after admission to detect the NT-ProBNP value. APACHE Ⅱscore was given upon their most severe clinical manifestations within 24 hours after admission. The patients were divided into a survival group( n = 38) and a death group( n = 12) according to their 28-day survival status. The NT-ProBNP level and APACHE Ⅱ score were compared between the two groups,and the correlation between NT-ProBNP and APACHE Ⅱ scores was analyzed. Results The plasma NT-proBNP level and APACHE Ⅱ score of patients in the death group were significantly higher than those of the survival group patients( P 0. 05). The NT-proBNP level and APACHE Ⅱ score were significantly correlated( P 0. 05); and the prognosis for patients with refractory heart failure was significantly correlated with their NT-proBNP level and APACHE Ⅱ score( P 0. 05). Conclusion The plasma NT-proBNP level of patients with refractory heart failure when they are admitted to ICU and their APACHE Ⅱ scores are closely related. There is a correlation between plasma NT-proBNP level,APACHE Ⅱ scores and the prognosis for patients with refractory heart failure,which can be considered as the predictor of short-term survival status of patients.
机构地区 中山市坦洲医院
出处 《现代医院》 2017年第11期1670-1672,共3页 Modern Hospitals
基金 中山市医学科研项目(编号:2016A020158)
关键词 难治性心力衰竭 血浆N末端脑钠肽原 急性生理与慢性健康评分 预后预测 Refractory Heart Failure NT-proBNP APACHE Prognosis
  • 相关文献

参考文献11

二级参考文献121

  • 1武育蓉,陈树宝,孙锟,黄美蓉,张玉奇,陈笋.现有儿科心力衰竭诊断标准及脑利钠肽对先天性心脏病合并心力衰竭的诊断价值[J].中华儿科杂志,2006,44(10):728-732. 被引量:37
  • 2陆再英.内科学[M].7版.北京:人民卫生出版社,2011:936.
  • 3陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2011:2193.
  • 4Denes P. Left bundle branch block and intermittant type A prexcita- tion[ J]. Chest,2010,4(41 ) :119-124.
  • 5Pollesello P, Papp Z. The eardioprotective effects of levosimendan: preclinical and clinical evidence[ J]. J Caiovasc Pharmaeol,2007, 50 ( 3 ) :257-263.
  • 6Lee SC, Stevens TL, Sandberg SM, et al. The potential ofbrain natri- uretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure [ J ]. J Card Fail, 2009,8 ( 3 ) : 149 -154.
  • 7Kota B, Prasad AS, Economides C, et al. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle:impact on heart failure [ J ]. J Cardiovase Pharmacol Ther, 2008,13 ( 4 ) : 269- 278.
  • 8Baba Y , Kubo T, Kitaoka H , et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis[J].Int Heart J,2012,53(5) :287-292.
  • 9Giannitsis E, Katus HA. Biomarkers : Pros and cons of high-sensi- tivity assays for cardiac troponin [ J]. Nat Rev Cardial, 2012,9 (11) :616-618.
  • 10Gollapudi S, Mamidi R, Mallampalli L, et al. The N-terminal exten- sion of cardiac troponin T stabilizes the blocked state of cardiac thin filament[ J ]. Biophys J ,2012,103 (5) :940-948.

共引文献172

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部